{"Abstract": [0], "Triple-negative": [1], "breast": [2, 9], "cancer": [3, 10], "(TNBC),": [4], "a": [5], "specific": [6], "subtype": [7], "of": [8, 74], "that": [11, 32], "does": [12], "not": [13, 56], "express": [14], "estrogen": [15], "receptor": [16, 19, 26], "(ER),": [17], "progesterone": [18], "(PR),": [20], "or": [21, 61], "human": [22], "epidermal": [23], "growth": [24], "factor": [25], "2": [27], "(HER-2),": [28], "has": [29, 79], "clinical": [30, 83], "features": [31], "include": [33], "high": [34, 36], "invasiveness,": [35], "metastatic": [37], "potential,": [38], "proneness": [39], "to": [40, 58, 114], "relapse,": [41], "and": [42, 51, 64, 92, 99, 105], "poor": [43], "prognosis.": [44], "Because": [45], "TNBC": [46, 66, 76, 97, 119], "tumors": [47], "lack": [48], "ER,": [49], "PR,": [50], "HER2": [52, 62], "expression,": [53], "they": [54], "are": [55, 69], "sensitive": [57], "endocrine": [59], "therapy": [60], "treatment,": [63], "standardized": [65], "treatment": [67, 77, 88, 107], "regimens": [68, 108], "still": [70], "lacking.": [71], "Therefore,": [72], "development": [73], "new": [75, 102, 116], "strategies": [78], "become": [80], "an": [81], "urgent": [82], "need.": [84], "By": [85], "summarizing": [86], "existing": [87], "regimens,": [89], "therapeutic": [90], "drugs,": [91], "their": [93], "efficacy": [94], "for": [95, 109, 118], "different": [96], "subtypes": [98], "reviewing": [100], "some": [101], "preclinical": [103], "studies": [104], "targeted": [106], "TNBC,": [110], "this": [111], "paper": [112], "aims": [113], "provide": [115], "ideas": [117], "treatment.": [120]}